Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
49.70    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (1.222%)
Market Cap: £197.86m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Board Change

27 Nov 2008 15:30

CLS HOLDINGS PLC ("CLS" or "the Company") BOARD CHANGES

The Board of CLS Holdings plc is pleased to announce the appointment of Mr Joseph Crawley and Mr Chris Jarvis as Non-executive Directors with immediate effect.

In addition, Mr James Dean is to retire on 31st December 2008 as a Non-executive Director after over nine years of valuable service. James has also made an important contribution as a member of both the Audit Committee and of the Remuneration Committee, of which he was Chairman. Thomas Lundqvist and Joseph Crawley will be appointed as Chairman and Member of the Remuneration Committee respectively, Chris Jarvis will be appointed as a member of the Audit Committee and Malcolm Cooper will replace James as the Senior Independent Director. These committee changes are expected to take effect on 31st December 2008.

Joseph Crawley is Chief Executive of Kitewood Estates Ltd, a property investment and development company active in London and south-east England. Kitewood specialises in supplying residential property to housing associations and also has a commercial business which is developing a business park in Kent. Joe has considerable experience, knowledge and contacts relating to the central London property market and has been active in property development in the London area for over 20 years. He was previously employed by CLS from 1988 to 1991 when he was responsible for property development, including the development of the Spring Gardens site. He was CLS' Development Director from 1995 to September 1999.

Chris Jarvis FRICS is senior partner of Jarvis & Partners, a boutique real estate consultancy that he established in Berlin in 1994. Jarvis & Partners acquired a leading role in advising major tenants and owner occupiers in Germany with a client list including Linklaters, Clifford Chance and the European Central Bank. Jarvis & Partners' work has been involved in advising a number of German equity investors and working with German based international corporates on sale and leaseback deals in Europe. Prior to establishing Jarvis & Partners, Chris worked for Richard Ellis for 13 years in London and Germany, from 1988 to 1994 as Managing Director of Richard Ellis Germany.

Sten Mortstedt, Chairman, commented:

"We are delighted that Joe and Chris have agreed to join the Board. The Board thanks James for all he has done for CLS and wishes him well for the future."

Pursuant to Listing Rule 9.6.13 (3) Joseph Allen Crawley was an Executive Director of Groveclose Ltd which was voluntarily liquidated in 2001 and he resigned as a Director of Trinity Modular Technology Ltd on 1 October 1995 which was later put into liquidation in July 1996. No further information is required to be disclosed pursuant to LR 9.6.13 R. Joe does not have any beneficial interests in CLS ordinary shares.

No information is required to be disclosed pursuant to LR 9.6.13 R in respect of Christopher Patrick Jarvis and he does not have any beneficial interests in CLS ordinary shares.

Enquiries:

Sten Mortstedt, Executive Chairman, CLS Holdings plc +44 (0) 20 7582 7766

Henry Klotz, Chief Executive Officer, CLS Holdings plc +44 (0) 20 7582 7766

vendor
Date   Source Headline
17th Jul 20197:00 amRNSDisposal
10th Jul 20198:44 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSAcquisition
4th Jul 20194:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20193:19 pmRNSDirector/PDMR Shareholding
28th Jun 20197:00 amRNSSale of Ateliers Victoires
27th Jun 20197:00 amRNSDirectorate Change
7th Jun 20193:32 pmRNSPDMR Notification
6th Jun 201910:51 amRNSPublication of Annual Sustainability Report
8th May 20196:18 pmRNSDirector/PDMR Shareholding
25th Apr 20195:01 pmRNSResult of AGM
8th Apr 20193:16 pmRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSCapital Markets Day Announcement
1st Apr 20199:00 amRNSAppointment of Chief Financial Officer
1st Apr 20197:00 amRNSAcquisition
26th Mar 20194:10 pmRNSHolding(s) in Company
22nd Mar 20194:39 pmRNSPublication of Annual Report and Notice of AGM
18th Mar 20199:33 amRNSDirector/PDMR Shareholding
7th Mar 20197:16 amRNSFinal Results
1st Mar 201911:38 amRNSDirectorate Change
20th Feb 20197:00 amRNSAcquisition
8th Feb 201912:22 pmRNSDirector/PDMR Shareholding
1st Feb 20192:17 pmRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSDisposal
9th Jan 20193:13 pmRNSDirector/PDMR Shareholding
21st Dec 20184:14 pmRNSDirector/PDMR Shareholding
21st Dec 201810:30 amRNSAcquisition
10th Dec 20184:50 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSTrading Statement
9th Nov 20186:27 pmRNSDirector/PDMR Shareholding
19th Oct 20185:51 pmRNSDirector/PDMR Shareholding
16th Oct 20187:00 amRNSDisposal
21st Sep 20185:51 pmRNSDirector/PDMR Shareholding
11th Sep 20182:58 pmRNSDirector/PDMR Shareholding
15th Aug 20187:00 amRNSHalf-year Report
13th Aug 201810:50 amRNSDirector/PDMR Shareholding
27th Jul 20181:51 pmRNSProposed early redemption of bonds due 2019
27th Jul 20187:00 amRNSDirectorate Change
6th Jul 20184:06 pmRNSDirector/PDMR Shareholding
29th Jun 20188:54 amRNSProposed early redemption of retail bond
14th Jun 201810:35 amRNSProposed early redemption of bonds
11th Jun 20185:12 pmRNSDirector/PDMR Shareholding
11th May 20185:21 pmRNSDirector/PDMR Shareholding
8th May 20184:56 pmRNSDirector/PDMR Shareholding
25th Apr 20182:14 pmRNSResult of AGM
25th Apr 201812:02 pmRNSPrice Monitoring Extension
10th Apr 20182:32 pmRNSDirector/PDMR Shareholding
4th Apr 20184:40 pmRNSSecond Price Monitoring Extn
4th Apr 20184:35 pmRNSPrice Monitoring Extension
23rd Mar 20185:02 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.